biopharma

Welcome to the 'biopharma' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biopharma'.

Latest blogosphere posts tagged “biopharma”

• ACCOUNTANT POSTS AT MUMBAI-VIRIDIS BIOPHARMA

  
  VFRESHERS — Authority: 157
  Accountant Job Positions India at Viridis BioPharma MumbaiJob Title : Accountant / Asst. AccountCompany Name : Viridis BioPharma Pvt. Ltd.About Company : Emerging Biotech / Pharma company with extensive R&D and having association / representation of various world renowned companies.Experience: 1 – 3 YearsJob ...
  5 hours ago

• Altair Therapeutics Raises $17M

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  San Diego-based Altair Therapeutics said Wednesday afternoon that it has raised $17M in a financing round. According to the firm, the round was led by Domain Associates, and also included AgeChem Venture Fund; Thomas, McNerney & Partners; Forward Ventures; and Isis Pharmaceuticals. The firm said the funding will ...
  3 days ago

• Partnerships In Clinical Trials Expands Its Global Reach

  
  Partnerships in Clinical Trials — Authority: 115
  The Institute for International Research is pleased to announce that as a chief component of its global branding strategy, the industry-leading Partnerships with CROs event is now known as Partnerships in Clinical Trials. In the nineteen years since the inception of the event, both the biopharmaceutical industry and ...
  5 days ago

• Trius Therapeutics Files For IPO

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  San Diego-based Trius Therapeutics has filed for an IPO, saying Friday that it is looking to raise $86.25M in an offering on the Nasdaq Global Market. According to the firms filing, it has applied to trade under the symbol TSRX. The IPO is being underwritten by Credit Suisse, Piper Jaffray, Canaccord Adams, and JMP ...
  5 days ago

• Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital Warts

  
  Information on HPV — Authority: 144
  Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano- Genital Warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II ...
  6 days ago

• Abraxis Health Expands In Arizona

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  Los Angeles-based Abraxis Health , the personalized healthcare division of Abraxis BioScience, said this morning that it is expanding in Arizona, and will open up a new biopharmaceuticals manufacturing plant in Phoenix. Abraxis said the plant will manufacture ABRAXANE, the firms chemotherapy treatment for metastatic ...
  1 week ago

• Joseph Moshe (MOSSAD Microbiologist): “Swine flu vaccine is bioweapon”

  
  War On You: Breaking Alternative News — Authority: 570
  Joseph Moshe (MOSSAD Microbiologist): “Swine flu vaccine is bioweapon” Posted on Unfictional.com Friday, August 21, 2009 Today, the MSM are not talking about this case any more. Yesterday, they wanted us to believe that Joseph Moshe was a nutcase and a terrorist, arrested for threatening to ...
  2 weeks ago

• Ligand Buys Metabasis

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  San Diego-based biopharmaceuticals firms Ligand Pharmaceuticals and Metabasis Therapeutics announced this morning that Ligand is acquiring Metabasis, in a deal worth $3.2M in cash plus rights to receive payments from any royalties or licensing of programs in the future. According to Metabasis CEO Mark D. Erion, ...
  2 weeks ago

• HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News

  
  Xconomy — Authority: 710
  Roundup , deals , VC Rebecca Zacks wrote: Lots of venture news this week, with more than the usual number of software and Web companies making appearances. — Flexion Therapeutics raised $33 million in a Series A round led by Versant Ventures and joined by 5AM Ventures and Sofinnova Partners. The ...
  3 weeks ago

• Flexion Pulls in $33M, Cubist Teams With Hydra, Charles River Makes Cuts, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Life Sciences , startups Rebecca Zacks wrote: There was a steady serenade of news from New England’s life sciences companies this past week, with both the startups and the public firms chiming in. —Ryan profiled Boston BioCom, a Pfizer-backed startup aiming to commercialize life science ...
  3 weeks ago

• Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice

  
  Science Blog - Science news straight from the source — Authority: 630
  Oxford, United Kingdom & Bothell, WA, USA -- October 20, 2009 -- An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.
  3 weeks ago

• Synageva Finishes $45M Round

  
  Xconomy — Authority: 710
  Life Sciences , deals , startups Ryan McBride wrote: Synageva BioPharma, a Waltham, MA-based developer of new and generic biotech drugs, said this morning that it has raised $12 million, on top of $33 million announced in May, to complete a $45 million round of financing. The round included previous ...
  3 weeks ago

• Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney

  
  Xconomy — Authority: 710
  Biotech , people , cancer Luke Timmerman wrote: Yesterday, we provided a rundown of the six hallmarks of a successful biotech company, according to Christopher Henney, the biotech pioneer who co-founded three of Seattle’s top biotechs—Immunex, Icos, and Dendreon. He made his remarks to an ...
  4 weeks ago

• Talecris Upcoming IPO: Ill Pass

  
  SeekingAlpha.com: Home Page — Authority: 676
  Complete Story » [IMG: http://static.seekingalpha.com/uploads/2009/9/14/442281-125297898341659-BioPharma-Investor.jpg]
  8 weeks ago

Comments about biopharma